Communicating risk in familial cancer: the European patient's perspective
Communicating risk in familial cancer: the European patient's perspective
Communicating risk in familial cancer: the European patient's perspective
Communicating risk in familial cancer: the European patient's perspective
Breast cancer research from ASCO 2010
Potential biologic causes of the racial survival disparity seen in breast cancer
PARP inhibitors
Prognostic and predictive markers in breast cancer
Circulating tumour cells in breast cancer
The influence of zoledronic acid on the treatment of endocrine-responsive early breast cancer
New agent eribulin prolongs survival in metastatic breast cancer
Roundup of the 2010 ASCO conference
Breast cancers that spread to the liver may change biology, impacting treatment effectiveness